A truncated HIV Tat demonstrates potent and specific latency reversal activity Article Swipe
Ellen Van Gulck
,
Marion Pardons
,
Erik Nijs
,
Nick Verheyen
,
Koen Dockx
,
Christel Van den Eynde
,
Emilie Battivelli
,
Jerel Vega
,
Éric Florence
,
Brigitte Autran
,
Nancie M. Archin
,
David M. Margolis
,
Christine Katlama
,
Chiraz Hamimi
,
Ilse Van den Wyngaert
,
Filmon Eyassu
,
Linos Vandekerckhove
,
Daniel Boden
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1128/aac.00417-23
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1128/aac.00417-23
A major barrier to HIV-1 cure is caused by the pool of latently infected CD4 T-cells that persist under combination antiretroviral therapy (cART). This latent reservoir is capable of producing replication-competent infectious viruses once prolonged suppressive cART is withdrawn. Inducing the reactivation of HIV-1 gene expression in T-cells harboring a latent provirus in people living with HIV-1 under cART may result in depletion of this latent reservoir due to cytopathic effects or immune clearance. Studies have investigated molecules that reactivate HIV-1 gene expression, but to date, no latency reversal agent has been identified to eliminate latently infected cells harboring replication-competent HIV in cART-treated individuals. Stochastic fluctuations in HIV-1 tat gene expression have been described and hypothesized to allow the progression into proviral latency. We hypothesized that exposing latently infected CD4+ T-cells to Tat would result in effective latency reversal. Our results indicate the capacity of a truncated Tat protein and mRNA to reactivate HIV-1 in latently infected T-cells ex vivo to a similar degree as the protein kinase C agonist: phorbol 12-myristate 13-acetate, without T-cell activation or any significant transcriptome perturbation.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1128/aac.00417-23
- OA Status
- hybrid
- Cited By
- 11
- References
- 100
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4387893729
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4387893729Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1128/aac.00417-23Digital Object Identifier
- Title
-
A truncated HIV Tat demonstrates potent and specific latency reversal activityWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-10-24Full publication date if available
- Authors
-
Ellen Van Gulck, Marion Pardons, Erik Nijs, Nick Verheyen, Koen Dockx, Christel Van den Eynde, Emilie Battivelli, Jerel Vega, Éric Florence, Brigitte Autran, Nancie M. Archin, David M. Margolis, Christine Katlama, Chiraz Hamimi, Ilse Van den Wyngaert, Filmon Eyassu, Linos Vandekerckhove, Daniel BodenList of authors in order
- Landing page
-
https://doi.org/10.1128/aac.00417-23Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1128/aac.00417-23Direct OA link when available
- Concepts
-
Provirus, Cart, Virus latency, Biology, Virology, Latency (audio), Ex vivo, CD8, Viral replication, Immune system, Virus, Gene, Immunology, In vivo, Genetics, Genome, Engineering, Mechanical engineering, Electrical engineeringTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
11Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 4, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
100Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4387893729 |
|---|---|
| doi | https://doi.org/10.1128/aac.00417-23 |
| ids.doi | https://doi.org/10.1128/aac.00417-23 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37874295 |
| ids.openalex | https://openalex.org/W4387893729 |
| fwci | 2.10295339 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D014775 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Virus Activation |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D017735 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Virus Latency |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D015496 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | CD4-Positive T-Lymphocytes |
| mesh[4].qualifier_ui | Q000235 |
| mesh[4].descriptor_ui | D011533 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | genetics |
| mesh[4].descriptor_name | Proviruses |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D015658 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | HIV Infections |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D014779 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Virus Replication |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D015496 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | CD4-Positive T-Lymphocytes |
| mesh[9].qualifier_ui | Q000235 |
| mesh[9].descriptor_ui | D015658 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | genetics |
| mesh[9].descriptor_name | HIV Infections |
| mesh[10].qualifier_ui | Q000378 |
| mesh[10].descriptor_ui | D015658 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | metabolism |
| mesh[10].descriptor_name | HIV Infections |
| mesh[11].qualifier_ui | Q000235 |
| mesh[11].descriptor_ui | D011533 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | genetics |
| mesh[11].descriptor_name | Proviruses |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D014775 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Virus Activation |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D017735 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Virus Latency |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D014779 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Virus Replication |
| mesh[15].qualifier_ui | Q000235 |
| mesh[15].descriptor_ui | D054322 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | genetics |
| mesh[15].descriptor_name | tat Gene Products, Human Immunodeficiency Virus |
| mesh[16].qualifier_ui | Q000378 |
| mesh[16].descriptor_ui | D054322 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | metabolism |
| mesh[16].descriptor_name | tat Gene Products, Human Immunodeficiency Virus |
| mesh[17].qualifier_ui | Q000235 |
| mesh[17].descriptor_ui | D015497 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | genetics |
| mesh[17].descriptor_name | HIV-1 |
| mesh[18].qualifier_ui | Q000378 |
| mesh[18].descriptor_ui | D015497 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | metabolism |
| mesh[18].descriptor_name | HIV-1 |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D015496 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | CD4-Positive T-Lymphocytes |
| mesh[21].qualifier_ui | Q000235 |
| mesh[21].descriptor_ui | D015658 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | genetics |
| mesh[21].descriptor_name | HIV Infections |
| mesh[22].qualifier_ui | Q000378 |
| mesh[22].descriptor_ui | D015658 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | metabolism |
| mesh[22].descriptor_name | HIV Infections |
| mesh[23].qualifier_ui | Q000235 |
| mesh[23].descriptor_ui | D011533 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | genetics |
| mesh[23].descriptor_name | Proviruses |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D014775 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Virus Activation |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D017735 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Virus Latency |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D014779 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Virus Replication |
| mesh[27].qualifier_ui | Q000235 |
| mesh[27].descriptor_ui | D054322 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | genetics |
| mesh[27].descriptor_name | tat Gene Products, Human Immunodeficiency Virus |
| mesh[28].qualifier_ui | Q000378 |
| mesh[28].descriptor_ui | D054322 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | metabolism |
| mesh[28].descriptor_name | tat Gene Products, Human Immunodeficiency Virus |
| mesh[29].qualifier_ui | Q000235 |
| mesh[29].descriptor_ui | D015497 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | genetics |
| mesh[29].descriptor_name | HIV-1 |
| mesh[30].qualifier_ui | Q000378 |
| mesh[30].descriptor_ui | D015497 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | metabolism |
| mesh[30].descriptor_name | HIV-1 |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D006801 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Humans |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D015496 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | CD4-Positive T-Lymphocytes |
| mesh[33].qualifier_ui | Q000235 |
| mesh[33].descriptor_ui | D015658 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | genetics |
| mesh[33].descriptor_name | HIV Infections |
| mesh[34].qualifier_ui | Q000378 |
| mesh[34].descriptor_ui | D015658 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | metabolism |
| mesh[34].descriptor_name | HIV Infections |
| mesh[35].qualifier_ui | Q000235 |
| mesh[35].descriptor_ui | D011533 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | genetics |
| mesh[35].descriptor_name | Proviruses |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D014775 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Virus Activation |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D017735 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Virus Latency |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D014779 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Virus Replication |
| mesh[39].qualifier_ui | Q000235 |
| mesh[39].descriptor_ui | D054322 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | genetics |
| mesh[39].descriptor_name | tat Gene Products, Human Immunodeficiency Virus |
| mesh[40].qualifier_ui | Q000378 |
| mesh[40].descriptor_ui | D054322 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | metabolism |
| mesh[40].descriptor_name | tat Gene Products, Human Immunodeficiency Virus |
| mesh[41].qualifier_ui | Q000235 |
| mesh[41].descriptor_ui | D015497 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | genetics |
| mesh[41].descriptor_name | HIV-1 |
| mesh[42].qualifier_ui | Q000378 |
| mesh[42].descriptor_ui | D015497 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | metabolism |
| mesh[42].descriptor_name | HIV-1 |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D006801 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Humans |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D015496 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | CD4-Positive T-Lymphocytes |
| mesh[45].qualifier_ui | Q000235 |
| mesh[45].descriptor_ui | D015658 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | genetics |
| mesh[45].descriptor_name | HIV Infections |
| mesh[46].qualifier_ui | Q000378 |
| mesh[46].descriptor_ui | D015658 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | metabolism |
| mesh[46].descriptor_name | HIV Infections |
| mesh[47].qualifier_ui | Q000235 |
| mesh[47].descriptor_ui | D011533 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | genetics |
| mesh[47].descriptor_name | Proviruses |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D014775 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Virus Activation |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D017735 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Virus Latency |
| type | article |
| title | A truncated HIV Tat demonstrates potent and specific latency reversal activity |
| awards[0].id | https://openalex.org/G52392250 |
| awards[0].funder_id | https://openalex.org/F4320313460 |
| awards[0].display_name | |
| awards[0].funder_award_id | HBC.2018.2278 |
| awards[0].funder_display_name | Agentschap Innoveren en Ondernemen |
| biblio.issue | 11 |
| biblio.volume | 67 |
| biblio.last_page | e0041723 |
| biblio.first_page | e0041723 |
| grants[0].funder | https://openalex.org/F4320313460 |
| grants[0].award_id | HBC.2018.2278 |
| grants[0].funder_display_name | Agentschap Innoveren en Ondernemen |
| topics[0].id | https://openalex.org/T10112 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2406 |
| topics[0].subfield.display_name | Virology |
| topics[0].display_name | HIV Research and Treatment |
| topics[1].id | https://openalex.org/T11020 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9966999888420105 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | Immune Cell Function and Interaction |
| topics[2].id | https://openalex.org/T10526 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9891999959945679 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | HIV/AIDS drug development and treatment |
| funders[0].id | https://openalex.org/F4320313460 |
| funders[0].ror | https://ror.org/032xdry56 |
| funders[0].display_name | Agentschap Innoveren en Ondernemen |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C102906071 |
| concepts[0].level | 4 |
| concepts[0].score | 0.8734246492385864 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q422467 |
| concepts[0].display_name | Provirus |
| concepts[1].id | https://openalex.org/C2777275308 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6871650218963623 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q234668 |
| concepts[1].display_name | Cart |
| concepts[2].id | https://openalex.org/C2778852064 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6714091300964355 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q4115619 |
| concepts[2].display_name | Virus latency |
| concepts[3].id | https://openalex.org/C86803240 |
| concepts[3].level | 0 |
| concepts[3].score | 0.6055393815040588 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[3].display_name | Biology |
| concepts[4].id | https://openalex.org/C159047783 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5937663912773132 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[4].display_name | Virology |
| concepts[5].id | https://openalex.org/C82876162 |
| concepts[5].level | 2 |
| concepts[5].score | 0.552730917930603 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q17096504 |
| concepts[5].display_name | Latency (audio) |
| concepts[6].id | https://openalex.org/C26291073 |
| concepts[6].level | 3 |
| concepts[6].score | 0.46073171496391296 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q310484 |
| concepts[6].display_name | Ex vivo |
| concepts[7].id | https://openalex.org/C167672396 |
| concepts[7].level | 3 |
| concepts[7].score | 0.45228832960128784 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q417800 |
| concepts[7].display_name | CD8 |
| concepts[8].id | https://openalex.org/C140704245 |
| concepts[8].level | 3 |
| concepts[8].score | 0.45147907733917236 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3933202 |
| concepts[8].display_name | Viral replication |
| concepts[9].id | https://openalex.org/C8891405 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4077778160572052 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[9].display_name | Immune system |
| concepts[10].id | https://openalex.org/C2522874641 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4016697108745575 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[10].display_name | Virus |
| concepts[11].id | https://openalex.org/C104317684 |
| concepts[11].level | 2 |
| concepts[11].score | 0.39144569635391235 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[11].display_name | Gene |
| concepts[12].id | https://openalex.org/C203014093 |
| concepts[12].level | 1 |
| concepts[12].score | 0.38595038652420044 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[12].display_name | Immunology |
| concepts[13].id | https://openalex.org/C207001950 |
| concepts[13].level | 2 |
| concepts[13].score | 0.3028540015220642 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q141124 |
| concepts[13].display_name | In vivo |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.18882513046264648 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| concepts[15].id | https://openalex.org/C141231307 |
| concepts[15].level | 3 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7020 |
| concepts[15].display_name | Genome |
| concepts[16].id | https://openalex.org/C127413603 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[16].display_name | Engineering |
| concepts[17].id | https://openalex.org/C78519656 |
| concepts[17].level | 1 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q101333 |
| concepts[17].display_name | Mechanical engineering |
| concepts[18].id | https://openalex.org/C119599485 |
| concepts[18].level | 1 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q43035 |
| concepts[18].display_name | Electrical engineering |
| keywords[0].id | https://openalex.org/keywords/provirus |
| keywords[0].score | 0.8734246492385864 |
| keywords[0].display_name | Provirus |
| keywords[1].id | https://openalex.org/keywords/cart |
| keywords[1].score | 0.6871650218963623 |
| keywords[1].display_name | Cart |
| keywords[2].id | https://openalex.org/keywords/virus-latency |
| keywords[2].score | 0.6714091300964355 |
| keywords[2].display_name | Virus latency |
| keywords[3].id | https://openalex.org/keywords/biology |
| keywords[3].score | 0.6055393815040588 |
| keywords[3].display_name | Biology |
| keywords[4].id | https://openalex.org/keywords/virology |
| keywords[4].score | 0.5937663912773132 |
| keywords[4].display_name | Virology |
| keywords[5].id | https://openalex.org/keywords/latency |
| keywords[5].score | 0.552730917930603 |
| keywords[5].display_name | Latency (audio) |
| keywords[6].id | https://openalex.org/keywords/ex-vivo |
| keywords[6].score | 0.46073171496391296 |
| keywords[6].display_name | Ex vivo |
| keywords[7].id | https://openalex.org/keywords/cd8 |
| keywords[7].score | 0.45228832960128784 |
| keywords[7].display_name | CD8 |
| keywords[8].id | https://openalex.org/keywords/viral-replication |
| keywords[8].score | 0.45147907733917236 |
| keywords[8].display_name | Viral replication |
| keywords[9].id | https://openalex.org/keywords/immune-system |
| keywords[9].score | 0.4077778160572052 |
| keywords[9].display_name | Immune system |
| keywords[10].id | https://openalex.org/keywords/virus |
| keywords[10].score | 0.4016697108745575 |
| keywords[10].display_name | Virus |
| keywords[11].id | https://openalex.org/keywords/gene |
| keywords[11].score | 0.39144569635391235 |
| keywords[11].display_name | Gene |
| keywords[12].id | https://openalex.org/keywords/immunology |
| keywords[12].score | 0.38595038652420044 |
| keywords[12].display_name | Immunology |
| keywords[13].id | https://openalex.org/keywords/in-vivo |
| keywords[13].score | 0.3028540015220642 |
| keywords[13].display_name | In vivo |
| keywords[14].id | https://openalex.org/keywords/genetics |
| keywords[14].score | 0.18882513046264648 |
| keywords[14].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1128/aac.00417-23 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S47215897 |
| locations[0].source.issn | 0066-4804, 1070-6283, 1098-6596 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0066-4804 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Antimicrobial Agents and Chemotherapy |
| locations[0].source.host_organization | https://openalex.org/P4310320263 |
| locations[0].source.host_organization_name | American Society for Microbiology |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320263 |
| locations[0].source.host_organization_lineage_names | American Society for Microbiology |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Antimicrobial Agents and Chemotherapy |
| locations[0].landing_page_url | https://doi.org/10.1128/aac.00417-23 |
| locations[1].id | pmh:oai:archive.ugent.be:01JMFB5ZBRNZQZM1R7ZVFV3GD4 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400477 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Ghent University Academic Bibliography (Ghent University) |
| locations[1].source.host_organization | https://openalex.org/I32597200 |
| locations[1].source.host_organization_name | Ghent University |
| locations[1].source.host_organization_lineage | https://openalex.org/I32597200 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | info:eu-repo/semantics/publishedVersion |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | ISSN: 1098-6596 |
| locations[1].landing_page_url | https://biblio.ugent.be/publication/01JMFB5ZBRNZQZM1R7ZVFV3GD4 |
| locations[2].id | pmid:37874295 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306525036 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | publishedVersion |
| locations[2].raw_type | |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | True |
| locations[2].raw_source_name | Antimicrobial agents and chemotherapy |
| locations[2].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37874295 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:10649039 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | cc-by |
| locations[3].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10649039/pdf/aac.00417-23.pdf |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/cc-by |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Antimicrob Agents Chemother |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10649039 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5055502798 |
| authorships[0].author.orcid | https://orcid.org/0009-0008-3343-0644 |
| authorships[0].author.display_name | Ellen Van Gulck |
| authorships[0].countries | BE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I137982388 |
| authorships[0].affiliations[0].raw_affiliation_string | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[0].institutions[0].id | https://openalex.org/I137982388 |
| authorships[0].institutions[0].ror | https://ror.org/04yzcpd71 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I137982388 |
| authorships[0].institutions[0].country_code | BE |
| authorships[0].institutions[0].display_name | Janssen (Belgium) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ellen Van Gulck |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[1].author.id | https://openalex.org/A5004217198 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-9921-8207 |
| authorships[1].author.display_name | Marion Pardons |
| authorships[1].countries | BE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2801227569 |
| authorships[1].affiliations[0].raw_affiliation_string | HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University , Ghent, Belgium |
| authorships[1].institutions[0].id | https://openalex.org/I2801227569 |
| authorships[1].institutions[0].ror | https://ror.org/00xmkp704 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2801227569 |
| authorships[1].institutions[0].country_code | BE |
| authorships[1].institutions[0].display_name | Ghent University Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Marion Pardons |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University , Ghent, Belgium |
| authorships[2].author.id | https://openalex.org/A5004116156 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Erik Nijs |
| authorships[2].countries | BE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I137982388 |
| authorships[2].affiliations[0].raw_affiliation_string | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[2].institutions[0].id | https://openalex.org/I137982388 |
| authorships[2].institutions[0].ror | https://ror.org/04yzcpd71 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I137982388 |
| authorships[2].institutions[0].country_code | BE |
| authorships[2].institutions[0].display_name | Janssen (Belgium) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Erik Nijs |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[3].author.id | https://openalex.org/A5087032584 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8017-741X |
| authorships[3].author.display_name | Nick Verheyen |
| authorships[3].countries | BE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I137982388 |
| authorships[3].affiliations[0].raw_affiliation_string | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[3].institutions[0].id | https://openalex.org/I137982388 |
| authorships[3].institutions[0].ror | https://ror.org/04yzcpd71 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I137982388 |
| authorships[3].institutions[0].country_code | BE |
| authorships[3].institutions[0].display_name | Janssen (Belgium) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Nick Verheyen |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[4].author.id | https://openalex.org/A5045226463 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Koen Dockx |
| authorships[4].countries | BE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I137982388 |
| authorships[4].affiliations[0].raw_affiliation_string | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[4].institutions[0].id | https://openalex.org/I137982388 |
| authorships[4].institutions[0].ror | https://ror.org/04yzcpd71 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I137982388 |
| authorships[4].institutions[0].country_code | BE |
| authorships[4].institutions[0].display_name | Janssen (Belgium) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Koen Dockx |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[5].author.id | https://openalex.org/A5017160342 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Christel Van den Eynde |
| authorships[5].countries | BE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I137982388 |
| authorships[5].affiliations[0].raw_affiliation_string | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[5].institutions[0].id | https://openalex.org/I137982388 |
| authorships[5].institutions[0].ror | https://ror.org/04yzcpd71 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I137982388 |
| authorships[5].institutions[0].country_code | BE |
| authorships[5].institutions[0].display_name | Janssen (Belgium) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Christel Van Den Eynde |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[6].author.id | https://openalex.org/A5006689293 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3297-0231 |
| authorships[6].author.display_name | Emilie Battivelli |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[6].affiliations[0].raw_affiliation_string | Janssen Infectious Diseases, A Division of Janssen Pharmaceutica NV , Brisbane, California, USA |
| authorships[6].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[6].institutions[0].ror | https://ror.org/05af73403 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Janssen (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Emilie Battivelli |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Janssen Infectious Diseases, A Division of Janssen Pharmaceutica NV , Brisbane, California, USA |
| authorships[7].author.id | https://openalex.org/A5075783390 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0998-4715 |
| authorships[7].author.display_name | Jerel Vega |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210110004 |
| authorships[7].affiliations[0].raw_affiliation_string | Arcturus Therapeutics, Science Center Drive , San Diego, California, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210110004 |
| authorships[7].institutions[0].ror | https://ror.org/01t92qx25 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210110004 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Arcturus Therapeutics (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Jerel Vega |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Arcturus Therapeutics, Science Center Drive , San Diego, California, USA |
| authorships[8].author.id | https://openalex.org/A5074588238 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-7004-9120 |
| authorships[8].author.display_name | Éric Florence |
| authorships[8].countries | BE |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I78281549 |
| authorships[8].affiliations[0].raw_affiliation_string | Institute of Tropical Medicine , Antwerp, Belgium |
| authorships[8].institutions[0].id | https://openalex.org/I78281549 |
| authorships[8].institutions[0].ror | https://ror.org/03xq4x896 |
| authorships[8].institutions[0].type | nonprofit |
| authorships[8].institutions[0].lineage | https://openalex.org/I78281549 |
| authorships[8].institutions[0].country_code | BE |
| authorships[8].institutions[0].display_name | Instituut voor Tropische Geneeskunde |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Eric Florence |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Institute of Tropical Medicine , Antwerp, Belgium |
| authorships[9].author.id | https://openalex.org/A5042701070 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3993-9336 |
| authorships[9].author.display_name | Brigitte Autran |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210128915 |
| authorships[9].affiliations[0].raw_affiliation_string | Faculty of Medicine Sorbonne-University, CIMI-Paris, UPMC/Inserm , Paris, France |
| authorships[9].institutions[0].id | https://openalex.org/I4210128915 |
| authorships[9].institutions[0].ror | https://ror.org/0375b8f90 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210096427, https://openalex.org/I4210128915 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Centre d'Immunologie et des Maladies Infectieuses |
| authorships[9].institutions[1].id | https://openalex.org/I154526488 |
| authorships[9].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[9].institutions[1].type | government |
| authorships[9].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[9].institutions[1].country_code | FR |
| authorships[9].institutions[1].display_name | Inserm |
| authorships[9].institutions[2].id | https://openalex.org/I39804081 |
| authorships[9].institutions[2].ror | https://ror.org/02en5vm52 |
| authorships[9].institutions[2].type | education |
| authorships[9].institutions[2].lineage | https://openalex.org/I39804081 |
| authorships[9].institutions[2].country_code | FR |
| authorships[9].institutions[2].display_name | Sorbonne Université |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Brigitte Autran |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Faculty of Medicine Sorbonne-University, CIMI-Paris, UPMC/Inserm , Paris, France |
| authorships[10].author.id | https://openalex.org/A5033471393 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-7938-0389 |
| authorships[10].author.display_name | Nancie M. Archin |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I114027177 |
| authorships[10].affiliations[0].raw_affiliation_string | University of North Carolina School of Medicine and UNC, HIV Cure Center , Chapel Hill, North Carolina, USA |
| authorships[10].institutions[0].id | https://openalex.org/I114027177 |
| authorships[10].institutions[0].ror | https://ror.org/0130frc33 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I114027177 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | University of North Carolina at Chapel Hill |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Nancie M. Archin |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | University of North Carolina School of Medicine and UNC, HIV Cure Center , Chapel Hill, North Carolina, USA |
| authorships[11].author.id | https://openalex.org/A5008716404 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5714-0002 |
| authorships[11].author.display_name | David M. Margolis |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I114027177 |
| authorships[11].affiliations[0].raw_affiliation_string | University of North Carolina School of Medicine and UNC, HIV Cure Center , Chapel Hill, North Carolina, USA |
| authorships[11].institutions[0].id | https://openalex.org/I114027177 |
| authorships[11].institutions[0].ror | https://ror.org/0130frc33 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I114027177 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | University of North Carolina at Chapel Hill |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | David M. Margolis |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | University of North Carolina School of Medicine and UNC, HIV Cure Center , Chapel Hill, North Carolina, USA |
| authorships[12].author.id | https://openalex.org/A5017386021 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-5093-4800 |
| authorships[12].author.display_name | Christine Katlama |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210121705, https://openalex.org/I4210133907, https://openalex.org/I39804081 |
| authorships[12].affiliations[0].raw_affiliation_string | Department Infectious Diseases, Hospital Pitié Salpetière, Sorbonne-University and IPLESP , Paris, France |
| authorships[12].institutions[0].id | https://openalex.org/I4210133907 |
| authorships[12].institutions[0].ror | https://ror.org/02qqh1125 |
| authorships[12].institutions[0].type | facility |
| authorships[12].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[12].institutions[1].id | https://openalex.org/I4210121705 |
| authorships[12].institutions[1].ror | https://ror.org/02mh9a093 |
| authorships[12].institutions[1].type | healthcare |
| authorships[12].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[12].institutions[1].country_code | FR |
| authorships[12].institutions[1].display_name | Pitié-Salpêtrière Hospital |
| authorships[12].institutions[2].id | https://openalex.org/I39804081 |
| authorships[12].institutions[2].ror | https://ror.org/02en5vm52 |
| authorships[12].institutions[2].type | education |
| authorships[12].institutions[2].lineage | https://openalex.org/I39804081 |
| authorships[12].institutions[2].country_code | FR |
| authorships[12].institutions[2].display_name | Sorbonne Université |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Christine Katlama |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department Infectious Diseases, Hospital Pitié Salpetière, Sorbonne-University and IPLESP , Paris, France |
| authorships[13].author.id | https://openalex.org/A5076005407 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Chiraz Hamimi |
| authorships[13].countries | FR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210128915 |
| authorships[13].affiliations[0].raw_affiliation_string | Faculty of Medicine Sorbonne-University, CIMI-Paris, UPMC/Inserm , Paris, France |
| authorships[13].institutions[0].id | https://openalex.org/I4210128915 |
| authorships[13].institutions[0].ror | https://ror.org/0375b8f90 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210096427, https://openalex.org/I4210128915 |
| authorships[13].institutions[0].country_code | FR |
| authorships[13].institutions[0].display_name | Centre d'Immunologie et des Maladies Infectieuses |
| authorships[13].institutions[1].id | https://openalex.org/I154526488 |
| authorships[13].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[13].institutions[1].type | government |
| authorships[13].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[13].institutions[1].country_code | FR |
| authorships[13].institutions[1].display_name | Inserm |
| authorships[13].institutions[2].id | https://openalex.org/I39804081 |
| authorships[13].institutions[2].ror | https://ror.org/02en5vm52 |
| authorships[13].institutions[2].type | education |
| authorships[13].institutions[2].lineage | https://openalex.org/I39804081 |
| authorships[13].institutions[2].country_code | FR |
| authorships[13].institutions[2].display_name | Sorbonne Université |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Chiraz Hamimi |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Faculty of Medicine Sorbonne-University, CIMI-Paris, UPMC/Inserm , Paris, France |
| authorships[14].author.id | https://openalex.org/A5077239206 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Ilse Van den Wyngaert |
| authorships[14].countries | BE |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I137982388 |
| authorships[14].affiliations[0].raw_affiliation_string | Discovery Sciences, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[14].institutions[0].id | https://openalex.org/I137982388 |
| authorships[14].institutions[0].ror | https://ror.org/04yzcpd71 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I137982388 |
| authorships[14].institutions[0].country_code | BE |
| authorships[14].institutions[0].display_name | Janssen (Belgium) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Ilse Van Den Wyngaert |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Discovery Sciences, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[15].author.id | https://openalex.org/A5023389714 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Filmon Eyassu |
| authorships[15].countries | BE |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I137982388 |
| authorships[15].affiliations[0].raw_affiliation_string | Discovery Sciences, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[15].institutions[0].id | https://openalex.org/I137982388 |
| authorships[15].institutions[0].ror | https://ror.org/04yzcpd71 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I137982388 |
| authorships[15].institutions[0].country_code | BE |
| authorships[15].institutions[0].display_name | Janssen (Belgium) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Filmon Eyassu |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Discovery Sciences, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium |
| authorships[16].author.id | https://openalex.org/A5076699359 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-8600-1631 |
| authorships[16].author.display_name | Linos Vandekerckhove |
| authorships[16].countries | BE |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I2801227569 |
| authorships[16].affiliations[0].raw_affiliation_string | HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University , Ghent, Belgium |
| authorships[16].institutions[0].id | https://openalex.org/I2801227569 |
| authorships[16].institutions[0].ror | https://ror.org/00xmkp704 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I2801227569 |
| authorships[16].institutions[0].country_code | BE |
| authorships[16].institutions[0].display_name | Ghent University Hospital |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Linos Vandekerckhove |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University , Ghent, Belgium |
| authorships[17].author.id | https://openalex.org/A5049875164 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Daniel Boden |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[17].affiliations[0].raw_affiliation_string | Janssen Infectious Diseases, A Division of Janssen Pharmaceutica NV , Brisbane, California, USA |
| authorships[17].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[17].institutions[0].ror | https://ror.org/05af73403 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Janssen (United States) |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | Daniel Boden |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Janssen Infectious Diseases, A Division of Janssen Pharmaceutica NV , Brisbane, California, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1128/aac.00417-23 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | A truncated HIV Tat demonstrates potent and specific latency reversal activity |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10112 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2406 |
| primary_topic.subfield.display_name | Virology |
| primary_topic.display_name | HIV Research and Treatment |
| related_works | https://openalex.org/W2005062239, https://openalex.org/W171718782, https://openalex.org/W1889931991, https://openalex.org/W2049653440, https://openalex.org/W2151937780, https://openalex.org/W2897841917, https://openalex.org/W1965444849, https://openalex.org/W2802839248, https://openalex.org/W3003880149, https://openalex.org/W2028244823 |
| cited_by_count | 11 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1128/aac.00417-23 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S47215897 |
| best_oa_location.source.issn | 0066-4804, 1070-6283, 1098-6596 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0066-4804 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Antimicrobial Agents and Chemotherapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310320263 |
| best_oa_location.source.host_organization_name | American Society for Microbiology |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320263 |
| best_oa_location.source.host_organization_lineage_names | American Society for Microbiology |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Antimicrobial Agents and Chemotherapy |
| best_oa_location.landing_page_url | https://doi.org/10.1128/aac.00417-23 |
| primary_location.id | doi:10.1128/aac.00417-23 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S47215897 |
| primary_location.source.issn | 0066-4804, 1070-6283, 1098-6596 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0066-4804 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Antimicrobial Agents and Chemotherapy |
| primary_location.source.host_organization | https://openalex.org/P4310320263 |
| primary_location.source.host_organization_name | American Society for Microbiology |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320263 |
| primary_location.source.host_organization_lineage_names | American Society for Microbiology |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Antimicrobial Agents and Chemotherapy |
| primary_location.landing_page_url | https://doi.org/10.1128/aac.00417-23 |
| publication_date | 2023-10-24 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3156537068, https://openalex.org/W2125377515, https://openalex.org/W2081550246, https://openalex.org/W2139250164, https://openalex.org/W2090646713, https://openalex.org/W2807106468, https://openalex.org/W2609863249, https://openalex.org/W2156075763, https://openalex.org/W1497870368, https://openalex.org/W2101516953, https://openalex.org/W2144549163, https://openalex.org/W1966916498, https://openalex.org/W2124058652, https://openalex.org/W3006940104, https://openalex.org/W2470126287, https://openalex.org/W2883329573, https://openalex.org/W2055796578, https://openalex.org/W1971112771, https://openalex.org/W2158867438, https://openalex.org/W2066848476, https://openalex.org/W2590296428, https://openalex.org/W2038598840, https://openalex.org/W1492921203, https://openalex.org/W2759353542, https://openalex.org/W2083880346, https://openalex.org/W2147447587, https://openalex.org/W1845845876, https://openalex.org/W2028613789, https://openalex.org/W2100859269, https://openalex.org/W2008966955, https://openalex.org/W2987871499, https://openalex.org/W1974488636, https://openalex.org/W2183611824, https://openalex.org/W2622181489, https://openalex.org/W4220660548, https://openalex.org/W2103409409, https://openalex.org/W2937740320, https://openalex.org/W2160076049, https://openalex.org/W2802298459, https://openalex.org/W2277732086, https://openalex.org/W2586226836, https://openalex.org/W2925601131, https://openalex.org/W2177904182, https://openalex.org/W2917160412, https://openalex.org/W2151980311, https://openalex.org/W2135018398, https://openalex.org/W3000922508, https://openalex.org/W1889176404, https://openalex.org/W2736822140, https://openalex.org/W3003788535, https://openalex.org/W3203007817, https://openalex.org/W3162836223, https://openalex.org/W2556485149, https://openalex.org/W2895775323, https://openalex.org/W2167867167, https://openalex.org/W4205822842, https://openalex.org/W4211084625, https://openalex.org/W2028440457, https://openalex.org/W2022627708, https://openalex.org/W2013357966, https://openalex.org/W1984064054, https://openalex.org/W2167778463, https://openalex.org/W2083804862, https://openalex.org/W2101296785, https://openalex.org/W1964660012, https://openalex.org/W2171770874, https://openalex.org/W2127672164, https://openalex.org/W2151217565, https://openalex.org/W2139833144, https://openalex.org/W2171228793, https://openalex.org/W2054350561, https://openalex.org/W1975786568, https://openalex.org/W1998439550, https://openalex.org/W2090084965, https://openalex.org/W1517343909, https://openalex.org/W2318289184, https://openalex.org/W2106051882, https://openalex.org/W1485557578, https://openalex.org/W2049653440, https://openalex.org/W1999690840, https://openalex.org/W2124620363, https://openalex.org/W2079713056, https://openalex.org/W2014017310, https://openalex.org/W2092524383, https://openalex.org/W2118015571, https://openalex.org/W2153747683, https://openalex.org/W2108499384, https://openalex.org/W2064914230, https://openalex.org/W1979630577, https://openalex.org/W1979861012, https://openalex.org/W1557881305, https://openalex.org/W2135900827, https://openalex.org/W1998346532, https://openalex.org/W2735653597, https://openalex.org/W1589352827, https://openalex.org/W2737789212, https://openalex.org/W2159096710, https://openalex.org/W2081098333, https://openalex.org/W2789029405, https://openalex.org/W2406250479 |
| referenced_works_count | 100 |
| abstract_inverted_index.A | 1 |
| abstract_inverted_index.C | 169 |
| abstract_inverted_index.a | 50, 146, 162 |
| abstract_inverted_index.We | 124 |
| abstract_inverted_index.as | 165 |
| abstract_inverted_index.by | 9 |
| abstract_inverted_index.ex | 159 |
| abstract_inverted_index.in | 47, 53, 62, 102, 107, 136, 155 |
| abstract_inverted_index.is | 7, 27, 38 |
| abstract_inverted_index.no | 87 |
| abstract_inverted_index.of | 12, 29, 43, 64, 145 |
| abstract_inverted_index.or | 72, 177 |
| abstract_inverted_index.to | 4, 69, 85, 94, 117, 132, 152, 161 |
| abstract_inverted_index.CD4 | 15 |
| abstract_inverted_index.HIV | 101 |
| abstract_inverted_index.Our | 140 |
| abstract_inverted_index.Tat | 133, 148 |
| abstract_inverted_index.and | 115, 150 |
| abstract_inverted_index.any | 178 |
| abstract_inverted_index.but | 84 |
| abstract_inverted_index.due | 68 |
| abstract_inverted_index.has | 91 |
| abstract_inverted_index.may | 60 |
| abstract_inverted_index.tat | 109 |
| abstract_inverted_index.the | 10, 41, 119, 143, 166 |
| abstract_inverted_index.CD4+ | 130 |
| abstract_inverted_index.This | 24 |
| abstract_inverted_index.been | 92, 113 |
| abstract_inverted_index.cART | 37, 59 |
| abstract_inverted_index.cure | 6 |
| abstract_inverted_index.gene | 45, 82, 110 |
| abstract_inverted_index.have | 76, 112 |
| abstract_inverted_index.into | 121 |
| abstract_inverted_index.mRNA | 151 |
| abstract_inverted_index.once | 34 |
| abstract_inverted_index.pool | 11 |
| abstract_inverted_index.that | 17, 79, 126 |
| abstract_inverted_index.this | 65 |
| abstract_inverted_index.vivo | 160 |
| abstract_inverted_index.with | 56 |
| abstract_inverted_index.HIV-1 | 5, 44, 57, 81, 108, 154 |
| abstract_inverted_index.agent | 90 |
| abstract_inverted_index.allow | 118 |
| abstract_inverted_index.cells | 98 |
| abstract_inverted_index.date, | 86 |
| abstract_inverted_index.major | 2 |
| abstract_inverted_index.under | 19, 58 |
| abstract_inverted_index.would | 134 |
| abstract_inverted_index.T-cell | 175 |
| abstract_inverted_index.caused | 8 |
| abstract_inverted_index.degree | 164 |
| abstract_inverted_index.immune | 73 |
| abstract_inverted_index.kinase | 168 |
| abstract_inverted_index.latent | 25, 51, 66 |
| abstract_inverted_index.living | 55 |
| abstract_inverted_index.people | 54 |
| abstract_inverted_index.result | 61, 135 |
| abstract_inverted_index.(cART). | 23 |
| abstract_inverted_index.Studies | 75 |
| abstract_inverted_index.T-cells | 16, 48, 131, 158 |
| abstract_inverted_index.barrier | 3 |
| abstract_inverted_index.capable | 28 |
| abstract_inverted_index.effects | 71 |
| abstract_inverted_index.latency | 88, 138 |
| abstract_inverted_index.persist | 18 |
| abstract_inverted_index.phorbol | 171 |
| abstract_inverted_index.protein | 149, 167 |
| abstract_inverted_index.results | 141 |
| abstract_inverted_index.similar | 163 |
| abstract_inverted_index.therapy | 22 |
| abstract_inverted_index.viruses | 33 |
| abstract_inverted_index.without | 174 |
| abstract_inverted_index.ABSTRACT | 0 |
| abstract_inverted_index.Inducing | 40 |
| abstract_inverted_index.agonist: | 170 |
| abstract_inverted_index.capacity | 144 |
| abstract_inverted_index.exposing | 127 |
| abstract_inverted_index.indicate | 142 |
| abstract_inverted_index.infected | 14, 97, 129, 157 |
| abstract_inverted_index.latency. | 123 |
| abstract_inverted_index.latently | 13, 96, 128, 156 |
| abstract_inverted_index.proviral | 122 |
| abstract_inverted_index.provirus | 52 |
| abstract_inverted_index.reversal | 89 |
| abstract_inverted_index.depletion | 63 |
| abstract_inverted_index.described | 114 |
| abstract_inverted_index.effective | 137 |
| abstract_inverted_index.eliminate | 95 |
| abstract_inverted_index.harboring | 49, 99 |
| abstract_inverted_index.molecules | 78 |
| abstract_inverted_index.producing | 30 |
| abstract_inverted_index.prolonged | 35 |
| abstract_inverted_index.reservoir | 26, 67 |
| abstract_inverted_index.reversal. | 139 |
| abstract_inverted_index.truncated | 147 |
| abstract_inverted_index.Stochastic | 105 |
| abstract_inverted_index.activation | 176 |
| abstract_inverted_index.clearance. | 74 |
| abstract_inverted_index.cytopathic | 70 |
| abstract_inverted_index.expression | 46, 111 |
| abstract_inverted_index.identified | 93 |
| abstract_inverted_index.infectious | 32 |
| abstract_inverted_index.reactivate | 80, 153 |
| abstract_inverted_index.withdrawn. | 39 |
| abstract_inverted_index.13-acetate, | 173 |
| abstract_inverted_index.combination | 20 |
| abstract_inverted_index.expression, | 83 |
| abstract_inverted_index.progression | 120 |
| abstract_inverted_index.significant | 179 |
| abstract_inverted_index.suppressive | 36 |
| abstract_inverted_index.12-myristate | 172 |
| abstract_inverted_index.cART-treated | 103 |
| abstract_inverted_index.fluctuations | 106 |
| abstract_inverted_index.hypothesized | 116, 125 |
| abstract_inverted_index.individuals. | 104 |
| abstract_inverted_index.investigated | 77 |
| abstract_inverted_index.reactivation | 42 |
| abstract_inverted_index.perturbation. | 181 |
| abstract_inverted_index.transcriptome | 180 |
| abstract_inverted_index.antiretroviral | 21 |
| abstract_inverted_index.replication-competent | 31, 100 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 18 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.85762712 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |